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The authors of this paper report a 5-year study
on 57 patients, using a polytetrafluoroethylene

(PTFE), small-diameter graft between the superior mesenteric vein and the inferior cava. These
operations were carried out when sclerotherapy
had failed, failure being defined as two recurrences of bleeding from the oesophageal varices
or one recurrence from gastric varices. The
reported results seem good, with only 3 deaths
(5%) in the post-operative period, and only 2
recurrences of haemorrhage in the immediate
post-operative period and one recurrent later
bleed in the second year after operation. The
incidence of encephalopathy was reported as 9
per cent, and was managed successfully by
protein restriction and/or lactulose treatement.
The cumulative patency rate of the shunt was 95
per cent. There was a 75 per cent actuarial survival
rate at 6 years.
The patients were extensively investigated

before, and after, operation. The operative techniques were standard apart from the use of a
PTFE graft. The patients were put on to heparin
initially intravenously and later subcutaneously,
to maintain a clotting level of twice normal.
Significant reduction in portal pressure was
achieved with shunt diameters of 10 and 12 millimetres. Prograde hepatic flow was preserved for
at least 3 years. Chronic encephalopathy did not
feature after shunting, but detailed description of
the results of pre- and post-operative tests for

encephalopathy were not provided.
The main criticism of the paper is that the
study was restricted to patients who had good
liver function, mainly Child-Pugh grade A and
B. In the experience of most clinicians in this
field, the majority of patients belong to the
Child-Pugh grade C. How did the authors treat
those in Child-Pugh grade C? Moreover, the
authors do not describe how they assessed the
severity of haemorrhage preceding these operations. Were these severe haemorrhages or mild,

but repeated, bleeds? There is good evidence that
the incidence of hepatic failure and encephalophy
after any type of shunt is remarkably low in
patients who have good liver function and who
have not bled severely.
There is no doubt that the interposition
mesocaval shunt is the easiest of all shunts to
perform. The shunt can be easily taken down if,
and when, liver transplant has to be undertaken.
The authors have an extensive experience in this
field, and have contributed significantly to the
surgical literature. However, since the early days
of end-to-side portacaval shunt, the tale has
always been the same. The first reports of a new
treatment have been most encouraging. The
initial studies have been undertaken in a small
number of highly-selected patients by an enthusiastic dedictated group. Only when the new
treatment has been undertaken in larger numbers, in a less selected group of patients, and
reported by a variety of groups, has pessimism
set in.
The use of PTFE graft for mesocaval interposition, therefore, is a useful technique for the
surgeon to keep at the back of his mind, for it is a
simple technique when the superior mesenteric
vein and the inferior vena cava are both patent.
The results of this paper apply only to a small
proportion of patients with bleeding oesophageal
varices, and it has not been proved that the results
are better than other forms of shunt. The authors
are invited to undertake a randomised control
trial comparing this technique with other established procedures.
Professor Sir Robert Shields
Oce of the President
The Royal College of Surgeons
of Edinburgh
Nicolson Street
Edinburgh EH8 9DW
United Kingdom
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Resection of Hilar Cholangiocarcinoma
ABSTRACT

Su, C.-H., Tsay, S.-H., Wu, C.-C., Shyr, Y.-M., King,
K.-L., Lee, C.-H., Lui, W.-Y., Liu, T.-J. and P’eng, F.-K.
(1996) Factors influencing postoperative morbidity, mortality and survival after resection for hilar cholangiocarcinoma. Annals

of Surgery, 223, 384-394.

Objective: Morbidity and mortality involved in the
resection of hilar cholangiocarcinoma were reviewed
retrospectively. The clinicopathologic and laboratory parameters that might influence the patient’s
survival also were re-evaluated.
Summary Background Data: Although much progress has been made in the diagnosis and management of hilar cholangiocarcinoma, long-term
outlook for most patients remains poor. Surgical
resection is usually prohibited because of its local
invasiveness, and most patients can only be mana-

ged by palliative drainage. Recently, many surgeons
have adopted a more aggressive resection with
varying degrees of success. Several prognostic
factors in bile duct carcinoma have been proposed;
however, no reports have specifically focused on
resected hilar cholangiocarcinoma and its prognostic
survival factors using multivariate analysis.
Methods: The clinical records and pathologic slides
of 49 cases with resected hilar cholangiocarcinoma
were reviewed retrospectively. Twenty clinical and
laboratory parameters were evaluated for their
correlation with postoperative morbidity and mortality, whereas 31 variables were evaluated for their
significance with postoperative survival. Variables
showing statistical significance in the first univariate analysis were included in the following multivariate analysis using stepwise logistic regression
test for factors affecting morbidity and mortality and
Cox stepwise proportional hazard model for factors
influencing survival.
Results: There were 5 in-hospital deaths, and the
cumulative 5-year survival rate in 44 patients who
survived was 14.9%, with a median survival of 14.0
months. Multivariate analysis disclosed that coexistent hepatolithiasis and lower serum asparate
aminotransferase levels (90 U/L) had a significant
low incidence of postoperative morbidity, whereas a
serum albumin of less than 3 g/dL was the only
significant factor affecting mortality. Regarding
survival, univariate analysis identified eight significant factors: 1) total bilirubin 10 mg/dL, 2) curative
resection, 3) histologic type, 4) perineural invasion,
5) liver invasion, 6) depth of cancer invasion, 7)
positive proximal resected margin, and 8) positive
surgical margin. However, multivariate analysis
disclosed total bilirubin _> 10 mg/dL, curative resec-

tion, and histologic type as the three most significant independent variables.
Conclusions: Surgical resection provides the best
survival for bilar cholangiocarcinoma. An adequate
nutritional support to increase serum albumin over
3g/dL is the most important factor to decrease
postoperative mortality. Moreover, preoperative
biliary drainage to decrease jaundice and a curative
resection with adequate surgical margin are recommended if longer survival is anticipated. Patients
with well differentiated adenocarcinoma seem to
survive longer compared to those with moderately or
poorly differentiated tumors.

Keywords: Hilar cholangiocarcinoma, liver resection, bile
duct resection

PAPER DISCUSSION
Suet al. have studied factors influencing surgical
outcomes in hilar cholangiocarcinoma using
univariate and multivariate analysis. 49 tumors
were resected over a period of about 13 years in
two hospitals in Taiwan, an average of about 4 per

year or 2 per year per hospital, although most of
the procedures were done in one hospital. Onehalf of the procedures were palliative, defined as
having microscopically or macroscopically involved resection margins. How many patients
had macroscopically involved versus microscopically involved margins is not stated. 5 patients
died in the postoperative period, 4 in the curative
group. The overall 5 year survival was 15% if one
excluded the 5 postoperative deaths. 5 year
survival in the curative group was about 35%,
and would have been about 30% had postoperative deaths not been excluded. No patient
who had a palliative resection survived 5 years.
All 49 patients were entered in the prognostic
analysis. 18 risk factors were examined for their
relation to morbidity and mortality by a univariate analysis in which the significance level was
set at p <0.05 level. Morbidity was reduced in
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patients with hepaticolithiasis and increased in
patients with high AST and these factors persisted
in the multivariate analysis. Low albumin and
low hemoglobin were significantly related to
mortality in the univariate analysis, but only the
former variable persisted in the multivariate
analysis. Although mortality rates were about 4
times higher (15.4% vs 4.3%) in patients over 65,
age was not significantly related to either morbidity or mortality in this analysis. Eight variables
were related to long term survival in the univariate analysis and elevated bilirubin, curative
resection and histologic type were found to be
significant in the multivariate analysis.
Comments: This is an interesting paper but there
are a number of methodological and theoretical
problems that render a number of the conclusions
questionable.
The statistical methods adopted by the authors
are well suited to analysis of large numbers of
patients, but not to the small sample size in this
study. Large numbers tend to assure that the data
is representative of the population, whereas
random non-representative events occurring in
only a few patients may result in erroneous
conclusions when the sample studied is small. Is
the finding that hepaticolithiasis protects against
morbidity one of these types of findings? Is it
merely chance that a few patients without stones
developed complications that led to this finding
or is hepaticolithiasis really protective? The
question is unanswerable, but much more confidence in the conclusion would be had if the
sample size were large instead of small. Another
problem with studies with small numbers is that
they lack power. One only needs to look at the fact
age was not found to be a significant factor in
morbidity despite the large difference in mortality rates in patients under and over age 65. In
other words small numbers renders these methods insensitive to variables that are truly significant and subject to concluding that truly nonsignificant variables are significant.
A second problem is that testing a large number
of variables against a probability standard that

approaches the number of variables being tested
will predictably result in finding of significance
simply by chance. For instance using the standard
p < 0.05 means that there is a 1 in 20 chance that
the finding of significance is due to chance. If, as
in this study, one examines 18 risk factors against
morbidity and mortality and use as probability
due to chance a standard of I in 20, there is a good
chance that significance will be found in one
variable due to chance. Statisticians usually deal
with this problem by lowering the p value at
which significance is declared from 0.05 by
division of 0.05 by the square root of the number
of variables tested. In this case an appropriate p
level would have been about 0.01 and not 0.05. Of
course this puts great pressure on the data when
the numbers are small. Only very striking and
obvious factors would be significant-for instance if hepaticolithiasis was a protective factor
then almost all patients without morbidity would
have to have this factor present for it to be
significant at the p < 0.01 level in this sample size.
A third problem relates to the fact that virtually
all statistical estimates have confidence limits.
These are critical to the interpretation of the data.
One type of confidence limit applies to odds
ratios. For instance one might find that the odds
of dying from an operative procedure at age over
65 were three times as great as dying from the
same procedure at age under 65 in a particular
data set. Yet, as impressive as this figure is, it is not
interpretable without the confidence limits of this
estimate. In one scenario the confidence limits
would include 1.0 (eg. 3.0 [0.5-6] confidence
limits given in square brackets). 1.0 is the nuli
hypothesis. It indicates no difference in odds
since the value 0.5 means that it is possible that
there is lesser chance of dying in the older group.
These results say that the estimate of difference
based on age includes the possibility that there is
no difference and the data is not significant. Data
of the form (3.0 [2.0-4.0]) excludes 1.0 and is
significant. This data says that the probability of
dying of the procedure in patients over 65 is
between 2 and 4 times greater than in patients
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under 65. In the study under discussion the
confidence limits of AST and hepaticolithiasis
as given in Table V appear to include 1 and are
therefore not significant in the multivariate
analysis, as is stated in the text.
On another level one might ask what is the
purpose of the survival analysis? Virtually all
studies including this one show that a positive
resection margin, i.e., a palliative resection, is
incompatible with long term survival. One does
not need sophisticated statistical techniques to
tell us this. In fact at this point are we not really
interested in detecting prognostic factors that
affect long term survival in patients who have
had curative resections only? In that case one
should only enter patients who have had
curative resection. Presumably the multivariate
nature of the model would preclude false
outcomes based on the fact that palliative and
curative resections were analyzed together.
Indeed curative resection was one of 3 factors
affecting long term outcome in the multivariate

analysis. Another factor, bilirubin >10mg%
was associated with poorer outcome and presumably this was not due to a tendency for

patients with higher bilirubin to have palliative
resection, since bilirubin was significant in the
multivariate analysis. Yet again one must look
at the confidence limits [0.17-0.99] which
means the data was barely significant. Greater
confidence would be gained by simply evaluating the effect of bilirubin in curatively resected
cases.

Here’s another point regarding multivariate
analyses that is not widely appreciated. Histologic grade was related to long term outcome.
Why wasn’t perineural invasion or depth of
invasion of tumor found to be significant as they
have been in other studies that the authors cite.
In order to understand this one must understand how the multivariate analysis works.
Each independent variable (eg. histologic grade,
perineural invasion) is examined in turn to see
how well it explains the variability of the results
for the independent variable (long term survi-
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val). When the factor that best explains the
variability is identified it is declared to be
related to the factor of interest, provided that
the relationship is significant. Other factors are
then tested for their ability to explain the
residual variability in the data, i.e., the data not
explained by the factor that best explains the
data. It is this part of the test that eliminates
independent variables that are related to other
independent variable and not to the dependent
variable. For instance in a study on the cause of
lung cancer one would find that while smoking
and alcohol might be related to the development
of lung cancer in a univariate analysis only
smoking is so in a multivariate analysis. The
finding in the univariate analysis is due to the
fact that smokers also tend to be drinkers. There
is however a fallout for this necessary procedure, which is that closely related independent
variables, which are truly related to the dependent variable, tend to predict the same type of
variability and the one which does it best will
depend to an extent on chance, especially in
small studies. The result is that if histologic grade
is found to explain variability better than perineural invasion even by a tiny margin it will be
the selected factor, but because they explain the
same variability, perineural invasion will not
explain residual variability well, and will be
found not to be significant. If the study is
repeated it is not unlikely that perineural invasion could eke out a numerical victory over
histologic grade and the opposite occur-it
would be the significant factor and not histologic
grade. In other words if one tests many closely
related factors (such as factors related to tumor
aggressiveness) it would not be surprising if they
were all positive in the univariate analysis, only
one was positive in the multivariate analysis and
that the one which was positive would vary from
study to study because there is no absolute
measure of tumor aggressiveness and what
comes out at the top in the analysis is largely
random. This is just what has happened in this
field and also in other prognostic studies such as
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studies examining prognosis of hepatic colorectal
cancer metastases.
What is to be done? Large co-operative studies
are needed since very few institutions can mount
a study with the numbers required. Beyond that
we probably need more help in understanding
the limits of resolution of statistical methods.
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